Nektar Therapeutics (NASDAQ:NKTR)
| 3.20 Delayed Data As of Sep 30 |  +0.16 / +5.26%Today’s Change | 2.96 Today|||52-Week Range 18.69 | -76.31% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Robin Howard W President & Chief Executive Officer |  Sale | 11/16/2021 | 42,773 | $13.16 | $562.9K | -75.92% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 8/18/2022 | 73,716 | $4.65 | $342.8K | -31.62% |
Labrucherie Gilbert M Chief Operating & Financial Officer & Senior VP | Sale | 11/16/2021 | 21,149 | $13.16 | $278.3K | -75.92% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 11/16/2021 | 20,869 | $13.16 | $274.6K | -75.92% |
Greer R Scott Director |  Buy | 11/09/2021 | 12,500 | $12.80 | $160.0K | -76.85% |
Robin Howard W President & Chief Executive Officer | Sale | 5/16/2022 | 36,529 | $3.95 | $144.3K | -17.53% |
Robin Howard W President & Chief Executive Officer | Sale | 2/16/2022 | 12,480 | $10.95 | $136.7K | -71.40% |
Zalevsky Jonathan Chief Research & Development Officer | Sale | 2/16/2022 | 10,912 | $10.95 | $119.5K | -71.40% |
Thomsen Jillian B Chief Accounting Officer & Senior Vice President | Sale | 11/16/2021 | 6,741 | $13.16 | $88.7K | -75.92% |
Wilson Mark A /nextkar/ General Counsel & Senior Vice President | Sale | 11/16/2021 | 6,564 | $13.16 | $86.4K | -75.92% |
Page of 6